A court said the notice-and-comment rulemaking process is not aligned with Congress' mandate that the FDA keep an up-to-date list of drugs in shortage. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
